SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand, with interim results expected by 2026 Joint R&D project between SK and CEPI includes up to ...
Vietnam Investment Review on MSN7h
AIM Vaccine s mRNA Shingles Vaccine Submits Clinical Application to the U SAnother Step Forward in Global Expansion HONG KONG, Feb. 25, 2025 /PRNewswire/ -- As global capital reassesses the investment value of innovative Chinese companies, the development of innovative ...
Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...
By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...
Allspring Global Investments Holdings LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 12.2% in the fourth quarter, Holdings Channel reports. The firm owned 15,368 shares of ...
Scientists explored the differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccines, and other viral ...
essanews.com on MSN19h
mRNA vaccine shows promise in tackling pancreatic cancerClinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most ...
Surveillance data showed there was no significant increase in sudden cardiac arrest among young athletes during the COVID ...
The Trump administration has started quietly re-hiring some of the FDA employees that it fired last week in a process that ...
GMP Human FGF-8b Protein (Cat. No. GMP-FGBH16) and Human FGF-8b Protein, Premium Grade (Cat. No. FGB-H5115) exhibit similar ...
With the modality now in early clinical trials, experts say more efficiency, broader editing capabilities and delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback